Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3304899367;99368;99369 chr2:178538687;178538686;178538685chr2:179403414;179403413;179403412
N2AB3140794444;94445;94446 chr2:178538687;178538686;178538685chr2:179403414;179403413;179403412
N2A3048091663;91664;91665 chr2:178538687;178538686;178538685chr2:179403414;179403413;179403412
N2B2398372172;72173;72174 chr2:178538687;178538686;178538685chr2:179403414;179403413;179403412
Novex-12410872547;72548;72549 chr2:178538687;178538686;178538685chr2:179403414;179403413;179403412
Novex-22417572748;72749;72750 chr2:178538687;178538686;178538685chr2:179403414;179403413;179403412
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: S
  • RefSeq wild type transcript codon: AGC
  • RefSeq wild type template codon: TCG
  • Domain: Fn3-129
  • Domain position: 51
  • Structural Position: 68
  • Q(SASA): 0.1717
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
S/G rs1330792517 -0.839 0.183 N 0.413 0.137 0.190952846119 gnomAD-2.1.1 4.02E-06 None None None None N None 6.46E-05 0 None 0 0 None 0 None 0 0 0
S/G rs1330792517 -0.839 0.183 N 0.413 0.137 0.190952846119 gnomAD-4.0.0 3.18265E-06 None None None None N None 5.65675E-05 0 None 0 0 None 0 0 0 0 3.02407E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
S/A 0.0693 likely_benign 0.0637 benign -0.513 Destabilizing 0.061 N 0.343 neutral None None None None N
S/C 0.0538 likely_benign 0.0437 benign -0.252 Destabilizing None N 0.305 neutral N 0.333893418 None None N
S/D 0.7345 likely_pathogenic 0.7714 pathogenic 0.285 Stabilizing 0.816 D 0.447 neutral None None None None N
S/E 0.8051 likely_pathogenic 0.819 pathogenic 0.365 Stabilizing 0.816 D 0.499 neutral None None None None N
S/F 0.3159 likely_benign 0.3265 benign -0.67 Destabilizing 0.836 D 0.58 neutral None None None None N
S/G 0.0844 likely_benign 0.0791 benign -0.808 Destabilizing 0.183 N 0.413 neutral N 0.436807142 None None N
S/H 0.5334 ambiguous 0.5209 ambiguous -1.049 Destabilizing 0.94 D 0.557 neutral None None None None N
S/I 0.1415 likely_benign 0.1453 benign 0.182 Stabilizing 0.351 N 0.511 neutral N 0.360807873 None None N
S/K 0.8901 likely_pathogenic 0.9012 pathogenic -0.017 Destabilizing 0.593 D 0.443 neutral None None None None N
S/L 0.1402 likely_benign 0.1652 benign 0.182 Stabilizing 0.129 N 0.433 neutral None None None None N
S/M 0.2257 likely_benign 0.2479 benign 0.049 Stabilizing 0.94 D 0.558 neutral None None None None N
S/N 0.1982 likely_benign 0.2203 benign -0.265 Destabilizing 0.77 D 0.505 neutral N 0.458625209 None None N
S/P 0.5336 ambiguous 0.6217 pathogenic -0.015 Destabilizing 0.94 D 0.571 neutral None None None None N
S/Q 0.681 likely_pathogenic 0.6875 pathogenic -0.181 Destabilizing 0.94 D 0.561 neutral None None None None N
S/R 0.8308 likely_pathogenic 0.8434 pathogenic -0.154 Destabilizing 0.921 D 0.573 neutral N 0.475997461 None None N
S/T 0.0887 likely_benign 0.0969 benign -0.233 Destabilizing 0.183 N 0.443 neutral N 0.424165918 None None N
S/V 0.1434 likely_benign 0.1451 benign -0.015 Destabilizing 0.264 N 0.467 neutral None None None None N
S/W 0.4772 ambiguous 0.4938 ambiguous -0.764 Destabilizing 0.983 D 0.624 neutral None None None None N
S/Y 0.2513 likely_benign 0.2422 benign -0.369 Destabilizing 0.94 D 0.583 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.